Literature DB >> 15060754

Is 11C-choline the most appropriate tracer for prostate cancer? Against.

Klaus Zöphel1, Jörg Kotzerke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15060754     DOI： 10.1007/s00259-004-1543-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  37 in total

1.  Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography.

Authors:  A Roivainen; S Forsback; T Grönroos; P Lehikoinen; M Kähkönen; E Sutinen; H Minn
Journal:  Eur J Nucl Med       Date:  2000-01

2.  Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.

Authors:  M Picchio; C Landoni; C Messa; L Gianolli; M Matarrese; F De Cobelli; A Del Maschio; F Fazio
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

3.  11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Authors:  Nobuyuki Oyama; Tom R Miller; Farrokh Dehdashti; Barry A Siegel; Keith C Fischer; Jeff M Michalski; Adam S Kibel; Gerald L Andriole; Joel Picus; Michael J Welch
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

4.  Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Authors:  Igle J de Jong; Jan Pruim; Philip H Elsinga; Willem Vaalburg; Han J Mensink
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

5.  MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.

Authors:  Nobuyuki Oyama; Joonyoung Kim; Lynne A Jones; Nicole M Mercer; John A Engelbach; Terry L Sharp; Michael J Welch
Journal:  Nucl Med Biol       Date:  2002-11       Impact factor: 2.408

6.  Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.

Authors:  G Bruwer; C F Heyns; F J Allen
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

7.  Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.

Authors:  Toshihiko Hara; Noboru Kosaka; Hiroichi Kishi
Journal:  J Nucl Med       Date:  2002-02       Impact factor: 10.057

8.  Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.

Authors:  Cherry T Thomas; Patrick T Bradshaw; Brad H Pollock; James E Montie; Jeremy M G Taylor; Howard D Thames; Patrick W McLaughlin; David A DeBiose; David H Hussey; Richard L Wahl
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

9.  Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases.

Authors:  Friedhelm Wawroschek; Harry Vogt; Hermann Wengenmair; Dorothea Weckermann; Michael Hamm; Mathias Keil; Gerhard Graf; Peter Heidenreich; Rolf Harzmann
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

10.  18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.

Authors:  Matthias T Wyss; Bruno Weber; Michael Honer; Nicolas Späth; Simon M Ametamey; Gerrit Westera; Beata Bode; Achim H Kaim; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-20       Impact factor: 9.236
View more
  2 in total

1.  Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Authors:  Ying Chen; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Mrudula Pullambhatla; James J Fox; Mark Castanares; Shawn E Lupold; John W Babich; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

2.  Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta R Banerjee; Catherine A Foss; Mark Castanares; Ronnie C Mease; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Journal:  J Med Chem       Date:  2008-07-19       Impact factor: 7.446
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.